Latest News

Solace Therapeutics, Inc., announced that Stefan De Wachter, MD, PhD will be presenting long-term data from the SOLECT Trial and Denise Elser, MD will be presenting a video presentation of the removal and replacement of the Vesair® Bladder Control Balloon during the 37th Annual AUGS Meeting in Denver, Colorado September 28-30th.

View full press release >

The Vesair Balloon Delivery System has CE mark and is not currently available in the US. It is for investigational use only.

©2017 Solace Therapeutics. All rights reserved.  AV-1015 Rev M • ReferencesPrivacy Policy

Site Design and Development by Conlega Design